BORTHAKUR, G., HUANG, X., KANTARJIAN, H., FADERL, S., RAVANDI, F., FERRAJOLI, A., . . . ISSA, J. (2010). Report of a phase 1/2 study of a combination of azacitidine and cytarabine in acute myelogenous leukemia and high-risk myelodysplastic syndromes.
Chicago Style CitationBORTHAKUR, GAUTAM, et al. Report of a Phase 1/2 Study of a Combination of Azacitidine and Cytarabine in Acute Myelogenous Leukemia and High-risk Myelodysplastic Syndromes. 2010.
MLA CitationBORTHAKUR, GAUTAM, et al. Report of a Phase 1/2 Study of a Combination of Azacitidine and Cytarabine in Acute Myelogenous Leukemia and High-risk Myelodysplastic Syndromes. 2010.
Warning: These citations may not always be 100% accurate.